摘要 |
The present invention relates to the use of 4-(4-Fluoro-2-methoxyphenyl)-N-{3-[(S- methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine (compound A), more particularly (+)-4-(4- Fluoro-2-methoxyphenyl)-N-{3-[(S-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine (compound A´), for treating gastric cancer, preferably gastric cancers in which cells have an amplification of the C-MYC gene. |